Gw&K Investment Management, LLC Catalent, Inc. Transaction History

Gw&K Investment Management, LLC

$11.7 Billion
Q3 2024

A detailed history of Gw&K Investment Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,454 shares of CTLT stock, worth $85,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,454

Previous 1,961 25.85%

Holding current value

$85,786

Previous $111,000 20.72%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$56.16 - $60.96 $28,473 - $30,906	-507 Reduced 25.85%	1,454 $88,000
Q2 2024 Aug 12, 2024	SELL	$53.58 - $57.02 $88,728 - $94,425	-1,656 Reduced 45.78%	1,961 $111,000
Q1 2024 May 08, 2024	SELL	$42.56 - $59.82 $21.6 Million - $30.3 Million	-506,796 Reduced 99.29%	3,617 $204,000
Q4 2023 Feb 09, 2024	SELL	$32.18 - $46.57 $868,023 - $1.26 Million	-26,974 Reduced 5.02%	510,413 $22.9 Million
Q3 2023 Nov 09, 2023	SELL	$44.2 - $50.2 $1.15 Million - $1.31 Million	-26,046 Reduced 4.62%	537,387 $24.5 Million
Q2 2023 Aug 09, 2023	SELL	$31.86 - $67.26 $24.4 Million - $51.6 Million	-767,040 Reduced 57.65%	563,433 $24.4 Million
Q1 2023 May 09, 2023	BUY	$45.44 - $74.26 $9.34 Million - $15.3 Million	205,640 Added 18.28%	1,330,473 $87.4 Million
Q4 2022 Feb 10, 2023	BUY	$41.39 - $81.0 $15.4 Million - $30.2 Million	373,210 Added 49.65%	1,124,833 $50.6 Million
Q3 2022 Nov 09, 2022	BUY	$72.36 - $113.1 $8.6 Million - $13.4 Million	118,898 Added 18.79%	751,623 $54.4 Million
Q2 2022 Aug 09, 2022	SELL	$87.2 - $114.05 $10.5 Million - $13.8 Million	-120,780 Reduced 16.03%	632,725 $67.9 Million
Q1 2022 May 09, 2022	BUY	$94.19 - $124.49 $5.02 Million - $6.64 Million	53,346 Added 7.62%	753,505 $83.6 Million
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $4.17 Million - $4.85 Million	34,895 Added 5.25%	700,159 $89.6 Million
Q3 2021 Nov 10, 2021	SELL	$109.17 - $142.35 $814,080 - $1.06 Million	-7,457 Reduced 1.11%	665,264 $88.5 Million
Q2 2021 Aug 10, 2021	BUY	$100.34 - $115.69 $940,587 - $1.08 Million	9,374 Added 1.41%	672,721 $72.7 Million
Q1 2021 May 11, 2021	BUY	$101.51 - $125.27 $8.17 Million - $10.1 Million	80,472 Added 13.81%	663,347 $69.9 Million
Q4 2020 Feb 05, 2021	BUY	$85.88 - $105.36 $57,883 - $71,012	674 Added 0.12%	582,875 $60.7 Million
Q3 2020 Nov 10, 2020	SELL	$72.74 - $92.5 $46.8 Million - $59.5 Million	-643,027 Reduced 52.48%	582,201 $49.9 Million
Q2 2020 Aug 06, 2020	SELL	$48.02 - $79.04 $29.6 Million - $48.7 Million	-616,267 Reduced 33.47%	1,225,228 $89.8 Million
Q1 2020 May 11, 2020	SELL	$36.95 - $62.95 $4.14 Million - $7.05 Million	-111,915 Reduced 5.73%	1,841,495 $95.7 Million
Q4 2019 Feb 10, 2020	SELL	$47.06 - $56.64 $2.68 Million - $3.22 Million	-56,863 Reduced 2.83%	1,953,410 $110 Million
Q3 2019 Nov 05, 2019	BUY	$47.45 - $58.05 $11.2 Million - $13.7 Million	235,371 Added 13.26%	2,010,273 $95.8 Million
Q2 2019 Aug 06, 2019	SELL	$39.26 - $54.21 $1.3 Million - $1.8 Million	-33,149 Reduced 1.83%	1,774,902 $96.2 Million
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $1.16 Million - $1.71 Million	-38,917 Reduced 2.11%	1,808,051 $73.4 Million
Q4 2018 Feb 07, 2019	SELL	$29.95 - $46.34 $1.24 Million - $1.91 Million	-41,266 Reduced 2.19%	1,846,968 $57.6 Million
Q3 2018 Nov 06, 2018	SELL	$40.12 - $45.55 $231,452 - $262,777	-5,769 Reduced 0.3%	1,888,234 $86 Million
Q2 2018 Aug 07, 2018	SELL	$38.72 - $42.52 $381,817 - $419,289	-9,861 Reduced 0.52%	1,894,003 $79.3 Million
Q1 2018 May 08, 2018	BUY	$39.4 - $47.39 $10.4 Million - $12.5 Million	263,963 Added 16.1%	1,903,864 $78.2 Million
Q4 2017 Jan 19, 2018	SELL	$37.27 - $43.02 $3.66 Million - $4.23 Million	-98,255 Reduced 5.65%	1,639,901 $67.4 Million
Q3 2017 Oct 11, 2017	BUY	$33.75 - $41.67 $58.7 Million - $72.4 Million	1,738,156	1,738,156 $69.4 Million

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Account

Gw&K Investment Management, LLC Catalent, Inc. Transaction History